Stocks and InvestingStocks and Investing
Fri, February 18, 2022
Thu, February 17, 2022
Wed, February 16, 2022
Tue, February 15, 2022

Madhu Kumar Initiated (SNDX) at Strong Buy and Held Target at $37 on, Feb 15th, 2022


Published on 2024-10-27 19:41:45 - WOPRAI, Madhu Kumar
  Print publication without navigation


Madhu Kumar of Goldman Sachs, Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy and Held Target at $37 on, Feb 15th, 2022.

Madhu, nor any peers, have made any analyst calls on SNDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30